TMO · CIK 0000097745 · operating
Thermo Fisher Scientific provides life sciences solutions, diagnostic instruments, laboratory products, and biopharma services across North America, Europe, Asia-Pacific, and internationally. The company operates through four primary segments serving pharmaceutical, biotechnology, academic, government, and clinical laboratory customers. Its offerings span reagents, instruments, and consumables for biological and medical research; drug discovery and vaccine production; infectious disease and condition diagnosis; and laboratory and biopharma support services.
The Life Sciences Solutions segment supplies reagents, instruments, and consumables for biological research, drug and vaccine development, and disease diagnosis. The Analytical Instruments segment provides instruments, software, and consumables for pharmaceutical, biotech, academic, and research markets, alongside clinical laboratory services. Specialty Diagnostics encompasses immunodiagnostic reagent kits, blood test systems for allergy and autoimmune disease monitoring, microbiology culture media and instrumentation, human leukocyte antigen typing for transplant diagnostics, and clinical consumables and diagnostic equipment. The Laboratory Products and Biopharma Services segment delivers laboratory products, research and safety solutions, and clinical research services.
Headquartered in Waltham, Massachusetts, Thermo Fisher operates under brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. The company reaches customers through direct sales, customer service teams, e-commerce, and third-party distributors. Incorporated in Delaware and listed on the NYSE, Thermo Fisher was founded in 1956.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $17.74 | $17.77 | +7.3% | |
| 2024 | $16.53 | $16.58 | +7.0% | |
| 2023 | $15.45 | $15.52 | -12.4% | |
| 2022 | $17.63 | $17.75 | -9.4% | |
| 2021 | $19.46 | $19.62 | +21.9% | |
| 2020 | $15.96 | $16.09 | +541.0% | |
| 2019 | $2.49 | $2.51 | +12.2% | |
| 2018 | $2.22 | $2.23 | +70.8% | |
| 2017 | $1.30 | $1.32 | -18.2% | |
| 2016 | $1.59 | $1.60 | +6.0% | |
| 2015 | $1.50 | $1.51 | +0.7% | |
| 2014 | $1.49 | $1.50 | +62.0% | |
| 2013 | $0.92 | $0.95 | -11.5% | |
| 2012 | $1.04 | $1.05 | +35.1% | |
| 2011 | $0.77 | $0.77 | +2.7% | |
| 2010 | $0.75 | $0.76 | -62.7% | |
| 2009 | $2.01 | $2.06 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0000097745-26-000018 | SEC ↗ |
| 2024-12-31 | 2025-02-20 | 0000097745-25-000010 | SEC ↗ |
| 2023-12-31 | 2024-02-22 | 0000097745-24-000007 | SEC ↗ |
| 2022-12-31 | 2023-02-23 | 0000097745-23-000008 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0000097745-22-000011 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0000097745-21-000011 | SEC ↗ |
| 2019-12-31 | 2020-02-26 | 0000097745-20-000009 | SEC ↗ |
| 2018-12-31 | 2019-02-27 | 0000097745-19-000007 | SEC ↗ |